These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2158392)
1. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Bungo M; Fujiwara Y; Kasahara K; Nakagawa K; Ohe Y; Sasaki Y; Irino S; Saijo N Cancer Res; 1990 May; 50(9):2549-53. PubMed ID: 2158392 [TBL] [Abstract][Full Text] [Related]
2. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines. Morikage T; Ohmori T; Nishio K; Fujiwara Y; Takeda Y; Saijo N Cancer Res; 1993 Jul; 53(14):3302-7. PubMed ID: 8391922 [TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines. Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. Hospers GA; Mulder NH; de Jong B; de Ley L; Uges DR; Fichtinger-Schepman AM; Scheper RJ; de Vries EG Cancer Res; 1988 Dec; 48(23):6803-7. PubMed ID: 2846161 [TBL] [Abstract][Full Text] [Related]
5. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines. Bando T; Fujimura M; Kasahara K; Matsuda T Anticancer Res; 1998; 18(2A):1085-9. PubMed ID: 9615770 [TBL] [Abstract][Full Text] [Related]
6. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Lai SL; Hwang J; Perng RP; Whang-Peng J Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042 [TBL] [Abstract][Full Text] [Related]
7. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616 [TBL] [Abstract][Full Text] [Related]
8. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line. Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. Saburi Y; Nakagawa M; Ono M; Sakai M; Muramatsu M; Kohno K; Kuwano M Cancer Res; 1989 Dec; 49(24 Pt 1):7020-5. PubMed ID: 2479474 [TBL] [Abstract][Full Text] [Related]
10. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance. Beketić-Oresković L; Osmak M; Jaksić M Neoplasma; 1994; 41(3):163-9. PubMed ID: 7935985 [TBL] [Abstract][Full Text] [Related]
11. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
12. Effect of proton pump inhibitor on cell growth and sensitivity to cis-diamminedichloroplatinum(II) in non-small cell lung cancer cell lines. Bando T; Kasahara K; Shibata K; Nakatsumi Y; Fujimura M; Matsuda T Anticancer Res; 1994; 14(6B):2727-30. PubMed ID: 7872708 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321 [TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873 [TBL] [Abstract][Full Text] [Related]
15. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair. Chao CC Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407 [TBL] [Abstract][Full Text] [Related]
16. cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines. Kuppen PJ; Schuitemaker H; van 't Veer LJ; de Bruijn EA; van Oosterom AT; Schrier PI Cancer Res; 1988 Jun; 48(12):3355-9. PubMed ID: 2897238 [TBL] [Abstract][Full Text] [Related]
17. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Johnson SW; Swiggard PA; Handel LM; Brennan JM; Godwin AK; Ozols RF; Hamilton TC Cancer Res; 1994 Nov; 54(22):5911-6. PubMed ID: 7954422 [TBL] [Abstract][Full Text] [Related]
18. [Establishment and characterization of human lung squamous-carcinoma sublines resistant to cis-diamminedichloroplatinum (II)]. Katabami M Hokkaido Igaku Zasshi; 1992 Jul; 67(4):531-41. PubMed ID: 1427597 [TBL] [Abstract][Full Text] [Related]
19. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair. Yang LY; Li L; Keating MJ; Plunkett W Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274 [TBL] [Abstract][Full Text] [Related]
20. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement. Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]